SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.
ISIN US00287YCS63
  • Abbvie
    Börse Börse München
    ISIN US00287YDA47
    Symbol 4AB
    EUR
  • Abbvie
    Börse Börse Frankfurt
    ISIN US00287YBP34
    Symbol 4AB
    EUR
  • Abbvie
    Börse Börse München
    ISIN US00287YCT47
    EUR
  • Abbvie
    Börse Tradegate System der Deutsche Börse AG (60%)
    ISIN US00287YCZ07
    Symbol 4AB
    EUR
  • ABBVIE INC
    Börse Börse Berlin
    ISIN US00287YBK47
    Symbol 4AB
    EUR
  • ABBVIE INC
    Börse Börse Düsseldorf
    ISIN US00287YCR80
    Symbol 4AB
    EUR
  • ABBVIE INC
    Börse Quotrix System der Börse Düsseldorf
    ISIN US00287YDB20
    Symbol 4AB
    EUR
  • ABBVIE INC
    Börse Gettex System der Börse München
    ISIN XS2125913603
    Symbol 4AB
    EUR
  • ABBVIE INC
    Börse Börse Stuttgart
    ISIN US00287YCU10
    Symbol 4AB
    EUR
  • ISIN US00287YAU38
    Symbol ABBV
    EUR
  • ISIN US00287YBY41
    BRL
  • ISIN US00287YCS63
    Symbol 4AB
  • ISIN US00287YCY32
    USD
  • ISIN US00287YCV92
    USD
  • AbbVie Inc.
    Börse Bolsa Mexicana de Valore Mexiko-Stadt
    ISIN US00287YBM03
  • AbbVie Inc.
    Börse Bolsa de Comercio de Buenos Aires
    ISIN US00287YBC21
ISIN US00287YCS63
Symbol 4AB
Marktkapitalisierung 291.000.000
Mitarbeiter 50.000

Abbvie outperformed den DAX um +29 % vom 17.05.2016 bis 27.08.2021

368 News & Informationen zur Abbvie Aktie

  • Continue To Ride Johnson & Johnson Stock For Higher Levels
    forbes.com

    Continue To Ride Johnson & Johnson Stock For Higher Levels

    We believe that the stock price of Johnson & Johnson has more room for growth from its current levels of $166. JNJ stock is up only 10% from the levels of around $150 it was at in mid-February, 2020, before the pandemic led to a steep correction in the stock markets. This marks an underperformance..

  • 3 Dividend Stocks That Are Dirt Cheap Right Now
    fool.com

    3 Dividend Stocks That Are Dirt Cheap Right Now

    Most stocks are priced at a premium. But these are bargains that also offer solid dividends.

  • On the congressional-comeback trail, Democrat Harley Rouda appears to violate the federal STOCK Act
    markets.businessinsider.com

    On the congressional-comeback trail, Democrat Harley Rouda appears to violate the federal STOCK Act

    Rep. Harley Rouda, a Democrat from California, appears to have violated a provision of the federal STOCK Act that's designed to make lawmake…

  • On the congressional-comeback trail, Democrat Harley Rouda appears to violate the federal STOCK Act
    businessinsider.com

    On the congressional-comeback trail, Democrat Harley Rouda appears to violate the federal STOCK Act

    Congress members love buying and selling stocks. Insider's weekly congressional financial report details how lawmakers are investing and making money.

  • Global $25+ Million Chloromethyl Isopropyl Carbonate (Value, Volume) Market to 2026
    markets.businessinsider.com

    Global $25+ Million Chloromethyl Isopropyl Carbonate (Value, Volume) Market to 2026

    DUBLIN, July 5, 2021 /PRNewswire/ — The 'Global Chloromethyl Isopropyl Carbonate (CMIC) Market (Value, Volume) – Analysis By Application, Type, B…

  • Global $25 Million Chloromethyl Isopropyl Carbonate (Value, Volume) Market To 2026
    thestreet.com

    Global $25 Million Chloromethyl Isopropyl Carbonate (Value, Volume) Market To 2026

    DUBLIN, July 5, 2021 /PRNewswire/ — The “Global Chloromethyl Isopropyl Carbonate (CMIC) Market (Value, Volume) – Analysis By Application, Type, By Region, By

  • Why AbbVie (ABBV) is a Top Dividend Stock for Your Portfolio
    zacks.com

    Why AbbVie (ABBV) is a Top Dividend Stock for Your Portfolio

    Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes? Let's find out.

  • 3 Warren Buffett Stocks to Buy in July
    fool.com

  • AbbVie Stock: The Path To 30% Annual Returns (NYSE:ABBV)
    seekingalpha.com

    AbbVie Stock: The Path To 30% Annual Returns (NYSE:ABBV)

    AbbVie has been over-punished for its looming loss of Humira. ABBV stock is way too cheap, and over time could see a rerating that bring 30% annual returns to investors. Read more here.

  • These COVID Therapies Appear to Be the Best and Worst at Treating New Variants
    fool.com

    These COVID Therapies Appear to Be the Best and Worst at Treating New Variants

    Here's how several leading COVID-19 antibody therapies compare based on pre-clinical testing.

  • How to Invest in Cannabis (Without Buying Cannabis Stocks)
    kiplinger.com

    How to Invest in Cannabis (Without Buying Cannabis Stocks)

    Ancillary companies provide cannabis businesses with materials, technology and services without ever “touching” the plant.

  • Insights On The Eye Care Global Market To 2026 - Featuring EssilorLuxottica, Bausch Health And Alcon Among Others
    thestreet.com

    Insights On The Eye Care Global Market To 2026 – Featuring EssilorLuxottica, Bausch Health And Alcon Among Others

    DUBLIN, July 2, 2021 /PRNewswire/ — The “Global Eye Care Market, By Product Type (Eyeglasses, Eye Drops, Contact Lens, Intraocular Lens, Eye Vitamins,

  • Got $400? 3 Fantastic Dividend Stocks to Buy Right Now
    fool.com

  • Worldwide Eye Care Industry to 2026 - Growing Prevalence of Different Ocular Problems is Driving Growth - ResearchAndMarkets.com
    news.google.com

    Worldwide Eye Care Industry to 2026 – Growing Prevalence of Different Ocular Problems is Driving Growth – ResearchAndMarkets.com

    The

  • Aesthetic Laser and Energy Devices Market in Health Care Equipment in the US | Technavio
    prnewswire.com

    Aesthetic Laser and Energy Devices Market in Health Care Equipment in the US | Technavio

    /PRNewswire/ — The healthcare equipment industry is expected to have a positive impact due to the spread of the COVID-19 pandemic. The market demand is…

  • Intrauterine Contraceptive Devices Market in Health Care Equipment Industry | Technavio
    markets.businessinsider.com

    Intrauterine Contraceptive Devices Market in Health Care Equipment Industry | Technavio

    NEW YORK, June 30, 2021 /PRNewswire/ –The healthcare industry is expected to have a positive impact due to the spread of the COVID-19 pandemic. T…

  • Intrauterine Contraceptive Devices Market in Health Care Equipment Industry | Technavio
    prnewswire.com

    Intrauterine Contraceptive Devices Market in Health Care Equipment Industry | Technavio

    /PRNewswire/ — The healthcare industry is expected to have a positive impact due to the spread of the COVID-19 pandemic. The market demand is expected to…

  • Top Biotech Companies by Market Cap
    investingnews.com

    Top Biotech Companies by Market Cap

    What are the biggest names in biotechnology? We count down the five top biotech companies based on market cap and share what they're up to.

  • AbbVie: Is the Price Right for Long-Term Investment?
    fool.com

    AbbVie: Is the Price Right for Long-Term Investment?

    The pharma giant's stock is up 18% in the past year. Have investors missed the boat or is the stock still a buy?

  • AbbVie Is Firing On All Cylinders (NYSE:ABBV)
    seekingalpha.com

    AbbVie Is Firing On All Cylinders (NYSE:ABBV)

    AbbVie is well on track to replace expected declines in future HUMIRA sales. Read more to know why ABBV looks primed to deliver a very strong decade.

  • Global Pharmaceutical Contract Manufacturing Market To Reach $130.2 Billion By 2026
    thestreet.com

    Global Pharmaceutical Contract Manufacturing Market To Reach $130.2 Billion By 2026

    SAN FRANCISCO, June 29, 2021 /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today

  • Global Pharmaceutical Contract Manufacturing Market to Reach $130.2 Billion by 2026
    prnewswire.com

    Global Pharmaceutical Contract Manufacturing Market to Reach $130.2 Billion by 2026

    /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled…

  • New York takes Teva, McKesson, others to trial over opioids By Reuters
    investing.com

    New York takes Teva, McKesson, others to trial over opioids By Reuters

    New York takes Teva, McKesson, others to trial over opioids

  • 3 Huge Monthly Dividends Set To Soar (One Yields An Incredible 7.6%)
    investing.com

    3 Huge Monthly Dividends Set To Soar (One Yields An Incredible 7.6%)

    Stocks Analysis by Contrarian Outlook (Brett Owens) covering: S&P 500, SPDR® S&P 500, iShares Biotechnology ETF, Amazon.com Inc. Read Contrarian Outlook (Brett Owens)'s latest article on Investing.com

  • Age-related Macular Degeneration Market In Pharmaceutical Industry | Technavio
    thestreet.com

    Age-related Macular Degeneration Market In Pharmaceutical Industry | Technavio

    NEW YORK, June 28, 2021 /PRNewswire/ — The age-related macular degeneration market will witness USD 4.00 billion growth during 2021-2025, according to the

  • SHAREHOLDER ALERT: WeissLaw LLP Reminds SPRT, MNR, UFS, and SOLY Shareholders About Its Ongoing Investigations
    prnewswire.com

    SHAREHOLDER ALERT: WeissLaw LLP Reminds SPRT, MNR, UFS, and SOLY Shareholders About Its Ongoing Investigations

    /PRNewswire/ — If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this…

  • Who Are the Dividend Aristocrats in 2021?
    visualcapitalist.com

    Who Are the Dividend Aristocrats in 2021?

    Dividend Aristocrats have grown dividends consecutively for at least 25 years. This infographic ranks all 65 companies by years and yield

  • Cabaletta Bio Appoints Biopharmaceutical Leader Scott Brun, M.D. To Board Of Directors
    thestreet.com

    Cabaletta Bio Appoints Biopharmaceutical Leader Scott Brun, M.D. To Board Of Directors

    Dr. Brun's early and late-stage clinical development expertise in autoimmune, neurologic, and renal disease areas aligns well with Cabaletta's rapidly emerging

  • These 3 High-Dividend Stocks Have Cathie Wood's Seal of Approval
    fool.com

    These 3 High-Dividend Stocks Have Cathie Wood's Seal of Approval

    Some might be surprised to see income-paying stocks among the ARK Invest founder's high-growth picks.

  • J&J to pay US$263m to settle opioid suits
    shanghaidaily.com

    J&J to pay US$263m to settle opioid suits

    JOHNSON & Johnson said on Saturday it will pay US$263 million to resolve claims it fueled an opioid epidemic in New York state and two of its largest counties.

    The settlements remove the drugmaker from

  • J&J to pay $263 million in New York opioid settlements, avoids trial
    marketscreener.com

    J&J to pay $263 million in New York opioid settlements, avoids trial

    NEW YORK -Johnson & Johnson said on Saturday it will pay $263 million to resolve claims it fueled an opioid epidemic in New York state and two of its largest counties….

  • Nike And Wells Fargo Lead The SPY Higher Friday
    benzinga.com

    Nike And Wells Fargo Lead The SPY Higher Friday

    U.S. indices continued higher Friday after President Joe Biden declared that the White House had struck an infrastructure deal with a bipartisan gr…

  • AbbVie (ABBV) Provides Update Regarding RINVOQ®
    marijuanastocks.com

  • How Will the Drop in Biogen’s Share Price Hit Buffett’s Portfolio? – 24
    247wallst.com

    How Will the Drop in Biogen’s Share Price Hit Buffett’s Portfolio? – 24

    One of six drugmakers in Berkshire Hathaway's portfolio, dropped by more than 6% on Thursday, but it remains the best performer of the six investments.

  • AbbVie : CHMP Recommends Approval of RINVOQ® (upadacitinib) for the Treatment of Atopic Dermatitis
    marketscreener.com

    AbbVie : CHMP Recommends Approval of RINVOQ® (upadacitinib) for the Treatment of Atopic Dermatitis

    NORTH CHICAGO, Ill., June 25, 2021 /PRNewswire/ — AbbVie today announced the European Medicines Agency's Committee for Medicinal Products for Human Use adopted a positive opinion recommending… | June 25, 2021

  • CHMP Recommends Approval of RINVOQ® (upadacitinib) for the Treatment of Atopic Dermatitis
    prnewswire.com

    CHMP Recommends Approval of RINVOQ® (upadacitinib) for the Treatment of Atopic Dermatitis

    /PRNewswire/ — AbbVie (NYSE: ABBV) today announced the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a…

  • JPMorgan Chase Top 50 Holdings : InvestmentClub
    reddit.com

    JPMorgan Chase Top 50 Holdings : InvestmentClub

    62.8k members in the InvestmentClub community. Where a virtual crowdsourced investment club manages a virtual $10M portfolio based on value and …

  • Redmile Group, LLC Buys Jazz Pharmaceuticals PLC, Seagen Inc, Medtronic PLC, Sells AbbVie Inc, Gilead Sciences Inc, 1Life Healthcare Inc
    gurufocus.com

    Redmile Group, LLC Buys Jazz Pharmaceuticals PLC, Seagen Inc, Medtronic PLC, Sells AbbVie Inc, Gilead Sciences Inc, 1Life Healthcare Inc

    GuruFocus Article or News written by insider and the topic is about:

  • AbbVie Inc. (ABBV) Exercises Right to Acquire TeneoOne
    marijuanastocks.com

  • 2 Marijuana Stocks To Watch Before The End Of The Month
    marijuanastocks.com

Schreibe einen Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile
  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen für Kommentare, die der Community helfen.

  • Mehr Informationen für alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

Portrait der Abbvie Aktie

Das Unternehmen Abbvie aus USA beschäftigt 50.000 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Biotechnologie & Pharmazeutika, Biotechnologie, Pharma tätig.

Die Abbvie Aktie konnte seit dem 17.05.2016 eine Rendite von 87% erwirtschaften.

Abbvie ist in mehr als 87 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter First Trust Morningstar Dividend Leaders ETF (CAD-Hedged) gewichtet Abbvie mit 7,03% im ETF.

Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Abbvie Anleihen auf einen Blick.

Entdecke die 6 ETFs in denen Abbvie am höchsten gewichtet ist Insgesamt in 87 ETFs enthalten

Dir gefallen die Informationen zu Abbvie?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:

Zu BUX Zero

Dir gefallen die Informationen zu Abbvie?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:

Zur ING Diba

Dir gefallen die Informationen zu Abbvie?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:

Zu Trade Republic

Dir gefallen die Informationen zu Abbvie?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:

Zur Comdirect